Oct 4 |
Novo Nordisk to invest $158 million in insulin plant in Brazil
|
Oct 4 |
Obesity is falling for the first time as Ozempic and weight loss drugs rise
|
Oct 4 |
What end of Eli Lilly's weight-loss drug shortage means for the competition
|
Oct 4 |
Eli Lilly's Mounjaro, Zepbound removed from FDA's shortage list
|
Oct 4 |
England's NHS Proposes Phased Rollout of Eli Lilly's Mounjaro, Considers Digital Services to Boost Access
|
Oct 4 |
As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer
|
Oct 4 |
The best funds to invest in according to expert research teams
|
Oct 3 |
Hims & Hers Health stock tanks after FDA says competitor Eli Lilly’s weight-loss drug shortage is over
|
Oct 3 |
Eli Lilly to Invest $4.5B for New Manufacturing & Research Plant
|
Oct 3 |
A mayor promises Ozempic for all and says there 'will be no more fat people' in his city
|